|
A British accent is not required at Oxford Bioscience Partners (OBP). The venture capital firm invests in biotech and health care companies at all stages of development, but it specializes in seed and early-stage enterprises. OBP typically invests between $1 million to $10 million per transaction and provides assistance to its portfolio companies by taking seats on their boards of directors, recruiting executives, and facilitating corporate partnerships. The company targets firms that utilize information technology or genomics to discover and develop new drug therapies, medical devices, research and development equipment, and other products.
|
| | | Contact Information | |
Address: |
222 Berkeley St., Ste. 1650
Boston, MA 02116
| | Phone: | 617-357-7474 | | Fax: | 617-357-7476 |
|
|
Key People
| | • |
Managing General Partner:
Jonathan J. Fleming
| | • |
CFO:
Raymond N. Charest
|
|
|
